LON:WAND Cirata (WAND) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cirata Stock (LON:WAND) Get Cirata alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume721,810 shsAverage Volume746,023 shsMarket Capitalization£72.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview WANdisco plc, together with its subsidiaries, engages in the development and provision of collaboration software in North America, Europe, China, and internationally. The company's WANdisco Data Activation Platform offers Data Migrator, an automated cloud migration solution that migrates HDFS data and Hive metadata to the cloud; Data Migrator for Azure, a native Azure service that enables users to migrate petabyte-scale Hadoop data and Hive metadata to the Azure cloud; and Edge to Cloud, a tool designed to move IoT and file data across edge systems, data centers, and public clouds to enable organizations to activate their data for AI, machine learning, and advanced analytics on modern cloud data platforms. Its application lifecycle management products include Subversion MultiSite Plus, Git MultiSite, Gerrit MultiSite, and Access Control Plus, as well as offers data migration services. WANdisco plc was founded in 2005 and is based in St. Helier, Jersey. Read More Receive WAND Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cirata and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WAND Stock News HeadlinesCirata Grants Performance-Linked Share Options to CTO and CROFebruary 4, 2026 | tipranks.comCirata Receives Final US$900,000 from BlueOptima for DevOps Asset SaleDecember 19, 2025 | tipranks.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.May 14 at 1:00 AM | Profits Run (Ad)Cirata Cleared by FCA, Embarks on New Growth ChapterNovember 27, 2025 | tipranks.comCirata Grants Share Options to CEO Stephen KellySeptember 12, 2025 | tipranks.comCirata Share Chat (CRTA)October 4, 2024 | lse.co.ukStormont stalemate: Labour will have no magic wandDecember 7, 2023 | bbc.comBWandisco PLC (WD4.SG)October 31, 2023 | uk.finance.yahoo.comSee More Headlines WAND Stock Analysis - Frequently Asked Questions How do I buy shares of Cirata? Shares of WAND stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Cirata own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cirata investors own include BAE Systems (BA), Greencore Group (GNC), Lloyds Banking Group (LLOY), AutoZone (AZO), boohoo group (BOO), Capita (CPI) and easyJet (EZJ). Industry, Sector and Symbol Stock ExchangeLON SectorComputer and Technology Industry Software - Application Sub-IndustryN/A Current SymbolLON:WAND CIKN/A Webwww.wandisco.com Phone+44-114-3039985FaxN/AEmployees127Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£45.17 million Net MarginsN/A Pretax MarginN/A Return on Equity-231.71% Return on Assets-76.89% Debt Debt-to-Equity Ratio136.67 Current Ratio0.93 Quick Ratio4.07 Sales & Book Value Annual Sales£6.85 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow11.89 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares114,720,000Free FloatN/AMarket Cap£72.96 million OptionableNot Optionable Beta0.70 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (LON:WAND) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersJ.P. Morgan is betting on this coinFor the first time in history, autonomous AI programs can hold, send, and receive funds — completely without h...Crypto 101 Media | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...Equiscreen | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredCollect $1,170 a month from silverI've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cirata plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cirata With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
